ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OND Oncopeptides AB

0.2395
-0.0085 (-3.43%)
17 May 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Oncopeptides AB TG:OND Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0085 -3.43% 0.2395 0.2365 0.242 0.245 0.245 0.245 1,000 22:50:14

Loan Facility

17/11/2003 11:28am

UK Regulatory


RNS Number:1344S
OverNet Data PLC
17 November 2003

17 November 2003

                        OverNet Data Plc (the "Company")

                                 Loan Facility

The Company has arranged an interest free convertible loan of up to #200,000
with Monument Capital LLC ("Monument").

The first tranche of the facility of #25,000 is payable to the Company
immediately and the second tranche of #175,000 is payable to the Company at any
time within 4 months of the first tranche, when called by the Company or
provided to the Company at Monument's option.

The loan is convertible in whole or part on one or more occasions until fully
converted into new ordinary shares of 0.5p on the basis of 1 new ordinary share
for each 10p of loan converted.

Monument is an LLC, owned by Paulo Mascheroni, which currently owns 1,276,000
ordinary shares in the Company.  Upon full conversion and assuming no further
new ordinary shares had been issued it would own 3,276,000 ordinary shares
representing 29.36% of the then issued ordinary share capital of the Company.
The directors believe that, having consulted with its nominated adviser, the
terms of the transaction are fair and reasonable insofar as its shareholders are
concerned.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCEAFFXFAKDFFE

1 Year Oncopeptides AB Chart

1 Year Oncopeptides AB Chart

1 Month Oncopeptides AB Chart

1 Month Oncopeptides AB Chart